A study of almost 13,000 patients shows that 31 per cent of them with the orders on or before their first day of admission to hospital.
Six in ten (59 per cent) of patients with a Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decision survived the illness while one in eight (12 per cent) received intensive treatment aimed at saving their life.
This is higher than the rates reported in previous studies of conditions similar to Covid-19 before the pandemic, according to a study from the University of Sheffield’s School of Health and Related Research (ScHARR).
The research, funded by the National Institute for Health Research, found 31 per cent of patients admitted to UK hospitals with suspected Covid-19 during the first wave of the pandemic had a DNACPR decision recorded before or on their day of admission to hospital.
The study, published in the journal Resuscitation, found people with a DNACPR decision received some intensive treatments as frequently as those with no DNACPR decision, which provides reassurance that doctors were not denying patients with DNACPR decisions potentially life-saving treatment.
The research also found that people of Asian background were less likely to have a DNACPR decision on or before their day of admission to hospital.
The reasons for this are not clear and the researchers highlighted the need for further studies into the discussions that take place when people from ethnic minorities are admitted to hospital with Covid-19 or other serious illnesses.
The findings come from the University of Sheffield-led Priest study, which was originally set up to evaluate ways of assessing the severity of Covid-19 in people attending emergency departments.
The research team analysed data relating to DNACPR decisions from 12,748 adults in the study after the Care Quality Commission undertook a review of the use of DNACPR decisions in the pandemic.
In March, the Care Quality Commission (CQC) called for ministerial involvement to tackle the “worrying variation” in people’s experiences of DNACPR decisions, with some families not properly involved and others unaware that decisions had been made.
It said that a combination of “unprecedented pressure” on providers and “rapidly developing guidance” may have led to situations where DNACPR decisions were incorrectly conflated with other clinical assessments.
There were examples of good practice but the regulator also found a “worrying picture” of poor involvement of people using services, poor record keeping, and a lack of oversight and scrutiny of the decisions being made.
Professor Steve Goodacre, professor of emergency medicine at the University of Sheffield’s ScHARR, said: “DNACPR decisions are an important element of providing appropriate care for seriously ill patients but they should not be used as a reason to withhold potentially life-saving treatment.
“Our findings show that many people who had a DNACPR decision during the first wave of the pandemic received an intensive life-saving treatment.”